UNSPSC 51422318: Melengestrol

This classification denotes a therapeutic progestin with the molecular formula C23H30O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, BX98J4T6JU chemically known as 17-hydroxy-6-methyl-16-methylenepregna-4,6-diene-3,20-dione but generally known as melengestrol, which bears US NIH Compound Identifier 21848. European Medicines Agency schedules Melengestrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08722MIG.

UNSPSC 51422318 Melengestrol is a Commodity code that in practice sees minimal state and local procurement activity aligned with its nominal scope. The single recent opportunity tagged under this code—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—does not match the pharmaceutical feed additive that the code name denotes. State and local governments do solicit medical supplies and public health products, but this particular code exhibits little relevant recent activity in that space.

The Seminole County IFB, posted June 30, 2026, with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The procurement required electronic submission through the county's e-Procurement Portal, included drug-free workplace and E-Verify compliance, and carried a two-year initial term with a one-year renewal option. Potential FEMA funding introduced additional federal compliance requirements. This represents a county health initiative rather than a categorical match to melengestrol procurement, and no additional state or local opportunities under this code appear in the recent record. Firms evaluating this code should treat it as inactive for practical state and local business development purposes and monitor for future activity that aligns with the code's intended agricultural-pharmaceutical scope.